We find that CF10 remains effective in CRC cells selected for 5-FU/LV resistance despite causing similar induction in TS, and this retained potency is associated with downregulation of c-Myc and ABCB5 at both the mRNA and protein levels. The gene discussed is ABCB5; the disease is colorectal carcinoma.